Answers are grounded in this paper and cite their sources.
Advanced glycation end products (AGEs) appear to contribute to the diabetic complications. This study reports the inhibitory effect of OPB-9195 (OPB), an inhibitor of AGEs formation, and the role of a collagen-specific molecular chaperone, a 47-kDa heat shock protein (HSP47) in diabetic nephropathy. Transgenic mice carrying nitric-oxide synthase cDNA fused with insulin promoter (iNOSTg) leads to diabetes mellitus. The iNOSTg mice at 6 months of age represented diffuse glomerulosclerosis, and the expression of HSP47 was markedly increased in the mesangial area in parallel with increased expression of types I and IV collagens. OPB treatment ameliorated glomerulosclerosis in the iNOSTg mice associated with the decreased expression of HSP47 and types I and IV collagens. The expression of transforming growth factor-β (TGF-β) was increased in glomeruli of iNOSTg mice and decreased after treatment with OPB. To confirm these mechanisms, cultured mesangial cells were stimulated with AGEs. AGEs significantly increased the expression of HSP47, type IV collagen, and TGF-β mRNA. Neutralizing antibody for TGF-β inhibited the overexpression of both HSP47 and type IV collagen in vitro. In conclusion, AGEs increase the expression of HSP47 in association with collagens, both in vivo and in vitro. The processes may be mediated by TGF-β. Advanced glycation end products (AGEs) appear to contribute to the diabetic complications. This study reports the inhibitory effect of OPB-9195 (OPB), an inhibitor of AGEs formation, and the role of a collagen-specific molecular chaperone, a 47-kDa heat shock protein (HSP47) in diabetic nephropathy. Transgenic mice carrying nitric-oxide synthase cDNA fused with insulin promoter (iNOSTg) leads to diabetes mellitus. The iNOSTg mice at 6 months of age represented diffuse glomerulosclerosis, and the expression of HSP47 was markedly increased in the mesangial area in parallel with increased expression of types I and IV collagens. OPB treatment ameliorated glomerulosclerosis in the iNOSTg mice associated with the decreased expression of HSP47 and types I and IV collagens. The expression of transforming growth factor-β (TGF-β) was increased in glomeruli of iNOSTg mice and decreased after treatment with OPB. To confirm these mechanisms, cultured mesangial cells were stimulated with AGEs. AGEs significantly increased the expression of HSP47, type IV collagen, and TGF-β mRNA. Neutralizing antibody for TGF-β inhibited the overexpression of both HSP47 and type IV collagen in vitro. In conclusion, AGEs increase the expression of HSP47 in association with collagens, both in vivo and in vitro. The processes may be mediated by TGF-β. Nephropathy is a morbid complication associated with diabetes mellitus and is the leading cause of end-stage renal disease (1Bojestig M. Arnqvist H.J. Hermansson G. Karlberg B.E. Ludvigsson J. N. Engl. J. Med. 1994; 330: 15-18Crossref PubMed Scopus (420) Google Scholar). Diabetic nephropathy is characterized by a mesangial expansion followed by glomerulosclerosis. The mechanism of these processes remains unknown. Advanced glycation end products (AGEs) 1The abbreviations used are: AGEs, advanced glycation end-products; HSP47, 47-kDa heat shock protein; iNOS, inducible nitric-oxide synthase; OPB, OPB-9195; TGF, transforming growth factor; CML, carboxymethyllysine; BSA, bovine serum albumin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; siRNA, small interfering RNA. 1The abbreviations used are: AGEs, advanced glycation end-products; HSP47, 47-kDa heat shock protein; iNOS, inducible nitric-oxide synthase; OPB, OPB-9195; TGF, transforming growth factor; CML, carboxymethyllysine; BSA, bovine serum albumin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; siRNA, small interfering RNA. have been recently reported to play an important role in the pathogenesis of diabetic complications, particularly in the progression of retinopathy and nephropathy (2Vlassara H. Bucala R. Striker L. Lab. Investig. 1994; 70: 138-151PubMed Google Scholar). AGEs, late compounds formed from early Amadori compounds produced during the Maillard reaction, slowly accumulate in various tissues. Direct evidence indicating the importance of AGEs in the progression of diabetic nephropathy has been reported previously (3Yamamoto Y. Kato I. Doi T. Yonekura H. Ohashi S. Takeuchi M. Watanabe T. Yamagishi S. Sakurai S. Takasawa S. Okamoto H. Yamamoto H. J. Clin. Investig. 2001; 108: 261-268Crossref PubMed Scopus (443) Google Scholar, 4Doi T. Vlassara H. Kirstein M. Yamada Y. Striker G.E. Striker L.J. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 2873-2877Crossref PubMed Scopus (325) Google Scholar, 5Iehara N. Takeoka H. Yamada Y. Kita T. Doi T. Kidney Int. 1996; 50: 1166-1172Abstract Full Text PDF PubMed Scopus (30) Google Scholar). The administration of exogenous AGEs to normal rats induces glomerular hypertrophy and mesangial sclerosis, gene expression of matrix proteins, and production of various growth factors. An inhibitor of AGEs formation, aminoguanidine, ameliorates the mild glomerular changes and functional changes found in streptozocin-induced diabetic rats (6Soulis-Liparota T. Cooper M. Papazoglou D. Clarke B. Jerums G. Diabetes. 1991; 40: 1328-1334Crossref PubMed Google Scholar). Recently, a synthetic thiazolidine derivative, OPB-9195, was shown to have a strong inhibitory effect of AGE formation (7Nakamura S. Makita Z. Ishikawa S. Yasumura K. Fujii W. Yanagisawa K. Kawata T. Koike T. Diabetes. 1997; 46: 895-899Crossref PubMed Google Scholar). The 47-kDa heat shock protein (HSP47) has been identified as a collagen-binding stress protein and plays a role in the intracellular processing of procollagen molecules as a collagen-specific molecular chaperone. We recently reported that the expression of HSP47 was markedly increased in parallel with the development of glomerulosclerosis in a rat renal ablation model (8Sunamoto M. Kuze K. Iehara N. Takeoka H. Nagata K. Kita T. Doi T. Int. J. Exp. Pathol. 1998; 79: 133-140Crossref PubMed Scopus (38) Google Scholar). We also found that the inhibition of HSP47 ameliorated glomerulosclerosis (9Sunamoto M. Kuze K. Tsuji H. Ohishi N. Yagi K. Nagata K. Kita T. Doi T. Lab. Investig. 1998; 78: 967-972PubMed Google Scholar). Despite a possible pathophysiological role of collagen-binding HSP47 in the fibrotic process in various organs, factors that modulate its expression remain undefined. To understand the pathogenesis of diabetic nephropathy and to develop prophylactic and therapeutic measures against it, suitable animal models are needed. However, no single animal model that develops the renal changes seen in humans is available. Spontaneously diabetic animals such as the non-obese diabetic mouse develop only limited lesions, at most mild mesangial sclerosis (10Doi T. Hattori M. Agodoa L.Y. Sato T. Yoshida H. Striker L.J. Striker G.E. Lab. Investig. 1990; 63: 204-212PubMed Google Scholar). The same is the case with chemically induced diabetic rodents. In this study, we analyzed transgenic mice carrying the mouse, type 2-inducible nitric-oxide synthase (iNOS) cDNA under the control of an insulin promoter (iNOSTg) (11Takamura T. Kato I. Kimura N. Nakazawa T. Yonekura H. Takasawa S. Okamoto H. J. Biol. Chem. 1998; 273: 2493-2496Abstract Full Text Full Text PDF PubMed Scopus (125) Google Scholar). The nitric oxide-mediated destruction of β cells results in a markedly reduced pancreatic islet mass and in the development of type 1 diabetes mellitus. These characteristics were followed by glomerulosclerosis that resembled human diabetic nephropathy (3Yamamoto Y. Kato I. Doi T. Yonekura H. Ohashi S. Takeuchi M. Watanabe T. Yamagishi S. Sakurai S. Takasawa S. Okamoto H. Yamamoto H. J. Clin. Investig. 2001; 108: 261-268Crossref PubMed Scopus (443) Google Scholar). Transforming growth factor (TGF)-β was originally identified in neoplastic cells and subsequently reported to be present in most cells in which it exerts a variety of effects on cell proliferation, cell differentiation, and embryogenesis. It has also been shown to stimulate the production of extracellular matrix components including collagens and fibronectin and to play a pivotal role in fibrogenesis (12Border W.A. Ruoslahti E. J. Clin. Investig. 1992; 90: 1-7Crossref PubMed Scopus (1038) Google Scholar). Thus, TGF-β is considered to be a mediator of collagen production in the models of fibrogenesis. Significant progress has recently been made in our understanding of the expression of the collagen genes and their transcriptional regulation by TGF-β (8Sunamoto M. Kuze K. Iehara N. Takeoka H. Nagata K. Kita T. Doi T. Int. J. Exp. Pathol. 1998; 79: 133-140Crossref PubMed Scopus (38) Google Scholar, 9Sunamoto M. Kuze K. Tsuji H. Ohishi N. Yagi K. Nagata K. Kita T. Doi T. Lab. Investig. 1998; 78: 967-972PubMed Google Scholar). A recent report has shown that high glucose transiently induces a transcriptional activity of c-fos responsible for stimulation of the TGF-β (13Weigert C. Brodbeck K. Bierhaus A. Haring H.U. Schleicher E.D. Biochem. Biophys. Res. Commun. 2003; 304: 301-307Crossref PubMed Scopus (28) Google Scholar). However, there is little information regarding the interaction between AGE and c-Fos. We investigated here the expression of c-Fos in cultured mesangial cells treated with AGE and examined whether c-Fos affected the expression of TGF-β. Furthermore, our recent report demonstrates that type IV collagen is up-regulated by AGE and its overexpression is transcriptionally regulated by Smad1 (14Abe H. Matsubara T. Iehara N. Nagai K. Takahashi T. Arai H. Kita T. Doi T. J. Biol. Chem. 2004; 279: 14201-14206Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar). Smad1 also enhances the levels of expression of type I collagen and osteopontin and plays a critical role in TGF-β-mediated overexpression of extracellular matrix in diabetic nephropathy (14Abe H. Matsubara T. Iehara N. Nagai K. Takahashi T. Arai H. Kita T. Doi T. J. Biol. Chem. 2004; 279: 14201-14206Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar). Therefore, we examined the role of Smad1 for regulating HSP47 expression by AGE stimulation in mesangial cells. In this study, we reported on a study of the inhibitory effect of OPB-9195 (OPB), a novel inhibitor of AGEs formation, in a model of diabetic nephropathy. The pathogenic role of HSP47 in the development of the glomerulosclerotic lesions in diabetes was examined. We also confirmed the mechanism of these processes with the use of cultured mesangial cells. Experimental Animals—iNOSTg were maintained on CD-1 mouse background (11Takamura T. Kato I. Kimura N. Nakazawa T. Yonekura H. Takasawa S. Okamoto H. J. Biol. Chem. 1998; 273: 2493-2496Abstract Full Text Full Text PDF PubMed Scopus (125) Google Scholar). Male littermates were screened for the transgenes by the PCR amplification and used for analysis. The primers used for the detection of iNOSTg were as follows: forward primer, 5′-GTGGGCTATGGGTTTGTGGAAGGAGA-3′, and reverse primer 5′-CGATGTCACATGCAGCTTGT-3′. No expression of iNOS protein, whose synthesis is directed only in pancreatic islets, was detected in the kidney. The mice were divided into four groups: CD-1 as control mice (Control); control mice treated with OPB (Control + OPB); iNOSTg; and iNOSTg treated with OPB (iNOSTg + OPB). Each group was fed either normal chow or the chow containing 0.28% OPB (provided by Fujii Memorial Research Institute, Otsuka Pharmaceutical, Tokushima, Japan) from 1 to 6 months after birth. Blood Glucose and HbA1c Concentration—The levels of blood glucose and HbA1c were measured from the tail vein blood using Dexter Z sensor (Bayer-Medical, Tokyo, Japan) and DCA2000 analyzer (Bayer-Medical), respectively. Determination of AGEs Concentration—Levels of serum carboxymethyllysine (CML) and non-CML AGEs were determined using a competitive enzyme-linked immunosorbent assay as described previously (15Takeuchi M. Makita Z. Yanagisawa K. Kameda Y. Koike T. Mol. Med. 1999; 5: 393-405Crossref PubMed Google Scholar). 1 unit/ml CML or non-CML AGEs corresponded to a protein concentration of 1 μg/ml CML-bovine serum albumin (BSA) or non-CML AGE-BSA, respectively. Renal Histology and Morphometric Analysis—Kidneys were processed for light microscopy examination, and the severity of the renal sclerosis was scored on an arbitrary scale from 0 to 4. The mean glomerular volume was determined as described previously (3Yamamoto Y. Kato I. Doi T. Yonekura H. Ohashi S. Takeuchi M. Watanabe T. Yamagishi S. Sakurai S. Takasawa S. Okamoto H. Yamamoto H. J. Clin. Investig. 2001; 108: 261-268Crossref PubMed Scopus (443) Google Scholar, 16Doi T. Striker L.J. Gibson C.C. Agodoa L.Y. Brinster R.L. Striker G.E. Am. J. Pathol. 1990; 137: 541-552PubMed Google Scholar). Immunofluorescence Analysis for HSP47, Types I and IV Collagens, and TGF-β —Immunofluorescence analysis was carried out as described previously using an affinity-purified polyclonal antibody specific to HSP47, types I and IV collagens, and TGF-β (8Sunamoto M. Kuze K. Iehara N. Takeoka H. Nagata K. Kita T. Doi T. Int. J. Exp. Pathol. 1998; 79: 133-140Crossref PubMed Scopus (38) Google Scholar, 9Sunamoto M. Kuze K. Tsuji H. Ohishi N. Yagi K. Nagata K. Kita T. Doi T. Lab. Investig. 1998; 78: 967-972PubMed Google Scholar). Laser-manipulated Microdissection and Laser Pressure Catapulating—Laser-manipulated microdissection is a method to cut out a small region from a specimen under microscope observation by means of laser beam. Laser is a method to and that have been using microdissection by means of a strong These were using the and an microscope K. G. 1998; PubMed Scopus Google Scholar). the glomeruli shown on the the glomeruli were cut out by the laser the for the laser be high to the glomeruli of the specimen into the which was in by the the laser was the glomeruli and were to the glomeruli for were from this were from of and mice at of was from and a cDNA synthesis was with reverse PCR was by using the detection for mouse glyceraldehyde-3-phosphate were used for The primers for HSP47, type IV collagen, and TGF-β were as follows: HSP47 primer, reverse primer, and type IV collagen primer, reverse primer, and and TGF-β primer, reverse primer, and The of the by activity of the the in an the of molecules is by the The were in the in which of the were in the The of PCR products was from the This detection on PCR at early PCR is L. W. L. J. U. W. Med. 1998; PubMed Scopus Google Scholar, K. M. M. N. K. Ohashi S. H. Kuze K. A. Kita T. Doi T. Am. J. Pathol. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). glomerular mesangial cell was from glomeruli from normal mice and was identified to a method described previously T. Vlassara H. Kirstein M. Yamada Y. Striker G.E. Striker L.J. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 2873-2877Crossref PubMed Scopus (325) Google Scholar, 5Iehara N. Takeoka H. Yamada Y. Kita T. Doi T. Kidney Int. 1996; 50: 1166-1172Abstract Full Text PDF PubMed Scopus (30) Google Scholar). The mesangial cells were on that were maintained in of with with 1 at at and serum The cells were with The cultured cells the previously described for glomerular mesangial cells K. Striker L.J. S. Brinster R.L. Striker G.E. Kidney Int. Full Text PDF PubMed Scopus Google Scholar). was by the method described previously N. Takeoka H. Yamada Y. Kita T. Doi T. Kidney Int. 1996; 50: 1166-1172Abstract Full Text PDF PubMed Scopus (30) Google Scholar, H. Iehara N. T. M. J. Arai H. K. Kita T. Doi T. Biochem. Biophys. Res. Commun. 1998; PubMed Scopus Google Scholar). was with glucose for at AGE was measured by the at a protein concentration of 1 was by glucose under the same as for and control and AGE protein, respectively. were determined by the method of using as the cells were in the bovine serum at in that been with or control at for the the cells were with and was using cells were at a concentration of 1 and either in the of μg/ml antibody or a control normal H. Iehara N. K. Kita T. Doi T. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus (30) Google Scholar). of the cells were and on reverse Smad1 for Smad1 was a with the of A with the of of are shown by small was used as a of in was as described previously (14Abe H. Matsubara T. Iehara N. Nagai K. Takahashi T. Arai H. Kita T. Doi T. J. Biol. Chem. 2004; 279: 14201-14206Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar). mesangial cells were in by to to using a of antibody for HSP47, type IV collagen, and TGF-β (8Sunamoto M. Kuze K. Iehara N. Takeoka H. Nagata K. Kita T. Doi T. Int. J. Exp. Pathol. 1998; 79: 133-140Crossref PubMed Scopus (38) Google Scholar, 9Sunamoto M. Kuze K. Tsuji H. Ohishi N. Yagi K. Nagata K. Kita T. Doi T. Lab. Investig. 1998; 78: 967-972PubMed Google and detected using an detection was from mesangial cells using the and an assay was as described previously (14Abe H. Matsubara T. Iehara N. Nagai K. Takahashi T. Arai H. Kita T. Doi T. J. Biol. Chem. 2004; 279: 14201-14206Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar, H. Iehara N. K. Kita T. Doi T. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus (30) Google Scholar). The were by the of type IV collagen from the of Smad1 from and the of from In mouse for HSP47 and c-fos and and TGF-β and was by reverse The PCR were to confirm to be and were into a the with an was in using The and the were at A and were to and the were for 1 at The were analyzed by The for the same as the for the specific mRNA. and c-fos was from were with to the in the of against was used as a Blood and AGE glucose levels of iNOSTg mice were and OPB no effect on this HbA1c levels were in iNOSTg mice that of was the detection serum levels of CML and non-CML AGEs were significantly in iNOSTg mice and and OPB treatment of iNOSTg mice to a to the control levels and of to with lesions in iNOSTg mice were as a diffuse of the mesangial matrix and the expansion of the mesangial area These lesions were ameliorated by treatment with OPB. OPB markedly the glomerulosclerosis of iNOSTg mice with no in glomerular No in glomerular cell were detected these of OPB in diabetic glomerulosclerosis. OPB markedly glomerulosclerosis in iNOSTg mice with no in of glomerular volume no in glomerular cell were of and of of and HSP47 to with only of type I collagen be detected in control it was in the mesangial area of glomeruli in iNOSTg OPB treatment decreased this IV collagen was in both the glomerular and the in control expression was increased in iNOSTg which decreased after treatment with OPB. also a increase in the expression of HSP47, which the expression of type I and type IV collagen and TGF-β in iNOSTg These were decreased as the of OPB treatment and of of HSP47, collagens, and TGF-β. A increase in the expression of HSP47 types I and IV collagens, and TGF-β was OPB treatment a of the of and IV in by of glomeruli from by microdissection and laser was used to the expression of HSP47 and type IV collagen in this diabetic nephropathy A increase in the expression of HSP47, type IV collagen, and was seen in iNOSTg and OPB treatment a by AGEs in confirm the cultured mesangial cells were stimulated with AGEs. AGEs significantly increased both HSP47 and type IV collagen In AGEs were found to the expression of TGF-β in cultured mesangial cells the levels of both HSP47 and type IV collagen increased in with the of TGF-β protein Neutralizing antibody for TGF-β inhibited overexpression of both HSP47 and type IV collagen a and of HSP47 and type IV collagen by antibody for TGF-β inhibited both HSP47 and type IV collagen in cultured mesangial cells of analysis of HSP47 and type IV collagen protein expression in cultured mesangial cells treated with AGE in the of antibody for TGF-β or control To the mechanism for of we investigated the expression of c-fos in mesangial cells. We found that AGE treatment a increase of c-fos by The of c-fos was in the of the specific in the of control with the inhibition of the of TGF-β was We examined the of Smad1 in TGF-β-mediated of HSP47 and type IV collagen We to effect in mesangial cells. cells with expression of HSP47 and type IV collagen after AGE stimulation with control This study that the collagen-specific protein, HSP47, is in glomerulosclerotic lesions in parallel with increased expression of collagens I and IV in diabetic nephropathy. The of the study also that AGEs are a factor in the synthesis of increased expression of both HSP47 and collagens in and in in study that of HSP47 and collagens may be TGF-β. is in the of and procollagen with a in the HSP47 is a collagen-binding stress protein and has been shown to be in the a with HSP47 in the which plays an important role as a collagen-specific molecular in the intracellular of procollagen molecules K. S. Yamada Biochem. Biophys. Res. Commun. PubMed Scopus Google Scholar, A. M. K. Nagata K. J. Biol. 1992; PubMed Scopus Google Scholar). The role of HSP47 in regulating of collagen molecules has been reported previously N. M. S. E. T. N. Nagata K. J. Biol. PubMed Scopus Google and transcriptional regulation for HSP47 expression was H. I. K. A. N. M. K. N. Nagata K. J. Biol. Chem. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar, K. K. H. H. N. Nagata K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). However, its role in in to in diabetic nephropathy and nephropathy is unknown. We and (8Sunamoto M. Kuze K. Iehara N. Takeoka H. Nagata K. Kita T. Doi T. Int. J. Exp. Pathol. 1998; 79: 133-140Crossref PubMed Scopus (38) Google Scholar, A. T. T. 1998; PubMed Scopus Google have that HSP47 in glomerulosclerosis is associated with collagen Furthermore, the of HSP47 with a of glomerular lesions in the rat model (9Sunamoto M. Kuze K. Tsuji H. Ohishi N. Yagi K. Nagata K. Kita T. Doi T. Lab. Investig. 1998; 78: 967-972PubMed Google Scholar). These that HSP47 is a factor in the development of various glomerular In this study, a of HSP47 to glomerulosclerosis in diabetic nephropathy was The of AGEs formation inhibited the of HSP47 and collagens, the gene expression of type IV collagen, extracellular matrix and glomerulosclerosis in diabetic nephropathy in AGEs also increased expression of both HSP47 and type IV collagen in vitro. Thus, our study that AGEs are a factor in the synthesis of both HSP47 and collagens in diabetic nephropathy in vivo and in vitro. The mechanism of these processes remains we that AGEs stimulate novel factors in gene expression for glomerulosclerosis N. Takeoka H. Yamada Y. Kita T. Doi T. Kidney Int. 1996; 50: 1166-1172Abstract Full Text PDF PubMed Scopus (30) Google Scholar). We have recently reported that Smad1 transcriptionally of type IV collagen under AGE stimulation (14Abe H. Matsubara T. Iehara N. Nagai K. Takahashi T. Arai H. Kita T. Doi T. J. Biol. Chem. 2004; 279: 14201-14206Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar). we also that the expression of HSP47 was regulated by Smad1 under AGE I. H. N. Nagata K. Biochem. Biophys. Res. Commun. 1998; PubMed Scopus Google has reported that TGF-β transcriptionally HSP47 gene Thus, Smad1 may in the TGF-β-mediated of It has been shown that TGF-β the production of extracellular matrix components including collagens and fibronectin and that it plays a role in glomerulosclerosis (12Border W.A. Ruoslahti E. J. Clin. Investig. 1992; 90: 1-7Crossref PubMed Scopus (1038) Google Scholar). TGF-β the expression of the collagen genes and their transcriptional In the promoter analysis of the collagen genes that the of collagen genes of their (13Weigert C. Brodbeck K. Bierhaus A. Haring H.U. Schleicher E.D. Biochem. Biophys. Res. Commun. 2003; 304: 301-307Crossref PubMed Scopus (28) Google Scholar). TGF-β also HSP47 gene expression in cell types I. H. N. Nagata K. Biochem. Biophys. Res. Commun. 1998; PubMed Scopus Google Scholar). We that TGF-β only collagen also HSP47 in mesangial cells. In we that c-Fos in the of TGF-β under AGE These that TGF-β and its are important for diabetic nephropathy. models of diabetic nephropathy are from human lesions (10Doi T. Hattori M. Agodoa L.Y. Sato T. Yoshida H. Striker L.J. Striker G.E. Lab. Investig. 1990; 63: 204-212PubMed Google Scholar, J. 1990; PubMed Scopus Google Scholar). the the iNOSTg mice advanced glomerular lesions that human diabetic glomerulosclerosis. the analysis of this we confirmed that glomerular hypertrophy is important in the development of diabetic nephropathy the iNOSTg mice glomerular hypertrophy in association with glomerulosclerosis. However, the of AGE formation a decreased of glomerulosclerosis with no evidence for glomerular The mechanism for this is the regulation of HSP47 and collagens to be of the control of glomerular be to the mechanism of these
No takes yet. Share an insight, caveat, or question.
Ohashi et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: